Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04941508
Other study ID # 17300621
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date June 25, 2021
Est. completion date November 5, 2021

Study information

Verified date November 2021
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of this study is to compare the efficacy of mother's recorded voice versus dexmedetomidine injection on postoperative agitation in children undergoing elective surgery.


Description:

A written informed consent will be taken from the patients' legal guardians.Patients will be assigned randomly to three groups (30 subjects each) to be anesthetized and either randomly assigned to listen to the mother's recorded voice at 2 times (in the holding area 3 minutes before induction of anesthesia till induction of anesthesia is ended) and (during emergence from anesthesia till complete recovery) (Group M) or will be given a single bolus of dexmedetomidine 0.2 ยต/kg IV at 2 times (in the holding area 3 minutes before induction of anesthesia) and (at the end of surgery) (Group D) or given the same volume of saline IV at 2 times (in the holding area 3 minutes before induction of anesthesia) and (at the end of surgery) (Group C).To keep blinding, group M will be injected IV with the same volume of saline at the same 2 times as in groups D & C while in groups D & C, headphones will be putted as in group M at the same 2 times with no recorded voice.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date November 5, 2021
Est. primary completion date November 3, 2021
Accepts healthy volunteers No
Gender All
Age group 4 Years to 9 Years
Eligibility Inclusion Criteria: - Children (age 4-9 years) - American Society of Anesthesiologists physical status (ASA) I-II who will be listed for outpatient elective surgery under general anesthesia. Exclusion Criteria: - Developmental delays - Neurological diseases - Deafness - Hearing impairment - Maternal mutism - Absence of the mother

Study Design


Intervention

Behavioral:
the mother's recorded voice
Children will be assigned to listen to the mother's recorded voice at 2 times (in the holding area 3 minutes before induction of anesthesia till induction of anesthesia is ended) and (during emergence from anesthesia till complete recovery).
Drug:
Dexmedetomidine
Children will be given a single bolus of dexmedetomidine 0.2 µ/kg IV at 2 times (in the holding area 3 minutes before induction of anesthesia) and (at the end of surgery).
Other:
saline 0.9% placebo
Children will be given the same volume of saline at 2 times (in the holding area 3 minutes before induction of anesthesia) and (at the end of surgery).

Locations

Country Name City State
Egypt Assiut university hospital Assiut
Egypt Omar Soliman Assuit

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

References & Publications (1)

Manyande A, Cyna AM, Yip P, Chooi C, Middleton P. Non-pharmacological interventions for assisting the induction of anaesthesia in children. Cochrane Database Syst Rev. 2015 Jul 14;(7):CD006447. doi: 10.1002/14651858.CD006447.pub3. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Pediatric anesthesia of emergence delirium (PAED) score Emergence delirium (ED) will be measured by the pediatric anesthesia of emergence delirium (PAED).The scores for each of the five listed behaviours(makes eye contact with caregiver, actions are purposeful,aware of surroundings, restless and inconsolable) are added to achieve a total score (maximum score of 20). A score of >12 yields 100% sensitivity and 94.5% specificity for the diagnosis of ED 2 hours Postoperative
Secondary Face, Legs, Activity, Cry, and Consolability (FLACC) score Pain will be measured by Face, Legs, Activity, Cry, and Consolability (FLACC) score ranging from 0 to 10 where 0= relaxed and no pain, 1-3= mild pain/discomfort, 4-6= moderate pain, 7-10= severe discomfort/pain. 24 hours Postoperative
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06387953 - Mitigation of Emergence Agitation Through Implementation of Masimo Bridge Therapy N/A
Completed NCT05313659 - Intramuscular Ketamine Effect on Postnasal Surgery Agitation Phase 2
Not yet recruiting NCT05245721 - Effect of Caudal Nalbuphine on Postoperative Emergence Agitation in Pediatrics Undergoing Infra-umbilical Surgeries Phase 1
Recruiting NCT04765488 - WashIn /WashOut Procedure To Prevent Agitation During Recovery After Inhalational Anesthesia With Sevoflurane N/A
Completed NCT06339385 - Management of PADIS in Emergency Intensive Care Unit
Completed NCT04018157 - Single Bolus Dose of Ketodex Versus Ketofol For Prevention Of Emergence Agitation In Adults Undergoing Nasal Surgeries Early Phase 1